HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early hypertension and prolonged mineralocorticoid therapy discontinuation in a child with salt-wasting 21-hydroxylase deficiency.

AuthorsM Wasniewska, M Valenzise, T Aversa, S Mirabelli, F De Luca, F L De Luca, F Lombardo
JournalJournal of endocrinological investigation (J Endocrinol Invest) Vol. 34 Issue 2 Pg. 159-61 (Feb 2011) ISSN: 1720-8386 [Electronic] Italy
PMID21502797 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Mineralocorticoids
  • Fludrocortisone
  • fludrocortisone acetate
  • Hydrocortisone
Topics
  • Adrenal Hyperplasia, Congenital (drug therapy, physiopathology)
  • Anti-Inflammatory Agents (adverse effects, therapeutic use)
  • Child, Preschool
  • Fludrocortisone (adverse effects, analogs & derivatives, therapeutic use)
  • Humans
  • Hydrocortisone (adverse effects, therapeutic use)
  • Hypertension (etiology)
  • Infant, Newborn
  • Male
  • Mineralocorticoids (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: